3

PDB13 PREDICTING INPATIENT HOSPITALIZATION RISKS FOR MEDICAID DIABETES PATIENTS

Year:
2008
Language:
english
File:
PDF, 69 KB
english, 2008
6

CM2 UTILIZATION AND PERSISTENCE OF ALISKIREN IN A REAL-WORLD ENVIRONMENT

Year:
2009
Language:
english
File:
PDF, 88 KB
english, 2009
10

PCN14: CHEMOTHERAPY-INDUCED NEUROPATHY IN OVARIAN CANCER COST EFFECTIVENESS ANALYSIS

Year:
2001
Language:
english
File:
PDF, 56 KB
english, 2001
12

PCV42 PERSISTENCE AND ADHERENCE TO STATIN THERAPY IN A MANAGED CARE SETTING

Year:
2004
Language:
english
File:
PDF, 65 KB
english, 2004
13

PIHI5 IMPACT OF BENEFIT DESIGN ON PDE-5 UTILIZATION AND COSTS IN A LARGE PBM DATABASE

Year:
2005
Language:
english
File:
PDF, 66 KB
english, 2005
14

PCV37 PREDICTING STATIN COMPLIANCE IN NEW STARTERS WITH PHARMACY CLAIMS

Year:
2005
Language:
english
File:
PDF, 65 KB
english, 2005
17

PDB29 THE EFFECT OF INSULIN TREATMENT ON HEALTH CARE UTILIZATION IN TYPE-II DIABETES

Year:
2005
Language:
english
File:
PDF, 64 KB
english, 2005
18

PCV39 PREDICTING ANTIHYPERTENSIVE DRUG UTILIZATION: AN APPLICATION OF LATENT CLASS MODELS

Year:
2006
Language:
english
File:
PDF, 45 KB
english, 2006
19

PCV57 DOES 90-DAY PRESCRIPTION SUPPLY AT RETAIL IMPROVE COMPLIANCE IN A MANAGED CARE SETTING]

Year:
2006
Language:
english
File:
PDF, 46 KB
english, 2006